Solid Biosciences Inc (NASDAQ: SLDB) kicked off on Monday, up 3.91% from the previous trading day, before settling in for the closing price of $4.60. Over the past 52 weeks, SLDB has traded in a range of $2.88-$15.05.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -28.11% over the last five years. While this was happening, its average annual earnings per share was recorded 28.30%. With a float of $68.10 million, this company’s outstanding shares have now reached $77.49 million.
The firm has a total of 100 workers. Let’s measure their productivity. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Solid Biosciences Inc (SLDB) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Solid Biosciences Inc is 12.13%, while institutional ownership is 54.14%. The most recent insider transaction that took place on Mar 11 ’25, was worth 9,924. In this transaction Director of this company bought 1,860 shares at a rate of $5.34, taking the stock ownership to the 2,960 shares. Before that another transaction happened on Feb 19 ’25, when Company’s 10% Owner bought 1,000,000 for $4.03, making the entire transaction worth $4,030,000. This insider now owns 5,034,582 shares in total.
Solid Biosciences Inc (SLDB) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 28.30% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.18% during the next five years compared to 41.25% growth over the previous five years of trading.
Solid Biosciences Inc (NASDAQ: SLDB) Trading Performance Indicators
Take a look at Solid Biosciences Inc’s (SLDB) current performance indicators. Last quarter, stock had a quick ratio of 5.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.04, a number that is poised to hit -0.56 in the next quarter and is forecasted to reach -2.13 in one year’s time.
Technical Analysis of Solid Biosciences Inc (SLDB)
Analysing the last 5-days average volume posted by the [Solid Biosciences Inc, SLDB], we can find that recorded value of 1.25 million was lower than the volume posted last year of 2.59 million. As of the previous 9 days, the stock’s Stochastic %D was 12.53%. Additionally, its Average True Range was 0.48.
During the past 100 days, Solid Biosciences Inc’s (SLDB) raw stochastic average was set at 43.98%, which indicates a significant increase from 20.74% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 91.35% in the past 14 days, which was lower than the 97.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.31, while its 200-day Moving Average is $6.13. Now, the first resistance to watch is $4.84. This is followed by the second major resistance level at $4.91. The third major resistance level sits at $5.02. If the price goes on to break the first support level at $4.67, it is likely to go to the next support level at $4.56. Should the price break the second support level, the third support level stands at $4.49.
Solid Biosciences Inc (NASDAQ: SLDB) Key Stats
The company with the Market Capitalisation of 370.42 million has total of 77,493K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -124,700 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -42,600 K.
